Late-onset hypophysitis after discontinuation of nivolumab treatment for advanced skin melanoma: a case report
Sign Up to like & getrecommendations! Published in 2021 at "BMC Endocrine Disorders"
DOI: 10.1186/s12902-021-00854-y
Abstract: Background Nivolumab is an anti-programmed cell death protein 1 antibody, typically used as cancer immunotherapy agent. Despite multiple clinical benefits it might cause autoimmune-related side-effects, often involving the endocrine system. To our knowledge, this is… read more here.
Keywords: treatment; discontinuation nivolumab; hypophysitis; case ... See more keywords